Whereas CD8+ T-cells destroy tumor cells through recognizing tumor-specific antigens in association with MHC class I molecules, NK cells function without the requirement for prolonged pre-activation, providing a first line of defense against tumor cells [35,36]. This evidence concerns the gene CD8A and neoplasm.